Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Feb 25, 2026
Hemagen Diagnostics Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | 2007 - 2003 |
|---|---|---|---|---|---|---|
Period Ending | Sep '12 Sep 30, 2012 | Sep '11 Sep 30, 2011 | Sep '10 Sep 30, 2010 | Sep '09 Sep 30, 2009 | Sep '08 Sep 30, 2008 | 2007 - 2003 |
| Revenue | 4.04 | 5.14 | 5.22 | 5.42 | 6.37 | Upgrade
|
| Revenue Growth (YoY) | -21.38% | -1.51% | -3.67% | -14.99% | 42.07% | Upgrade
|
| Cost of Revenue | 2.43 | 3.18 | 2.86 | 3.18 | 3.6 | Upgrade
|
| Gross Profit | 1.61 | 1.96 | 2.36 | 2.23 | 2.77 | Upgrade
|
| Selling, General & Admin | 2.01 | 2.43 | 2.1 | 2.33 | 2.51 | Upgrade
|
| Research & Development | 0.04 | 0.01 | 0.03 | 0.09 | 0.15 | Upgrade
|
| Operating Expenses | 2.05 | 2.43 | 2.12 | 2.42 | 2.65 | Upgrade
|
| Operating Income | -0.44 | -0.47 | 0.24 | -0.19 | 0.12 | Upgrade
|
| Interest Expense | -0.47 | -0.41 | -0.33 | -0.4 | -0.38 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -0.91 | -0.88 | -0.09 | -0.59 | -0.24 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | 0 | 0.03 | 0.04 | - | Upgrade
|
| Asset Writedown | - | - | - | -0.16 | - | Upgrade
|
| Pretax Income | -0.91 | -0.88 | -0.07 | -0.71 | -0.24 | Upgrade
|
| Income Tax Expense | - | 0 | 0.09 | 0.02 | 0.13 | Upgrade
|
| Earnings From Continuing Operations | -0.91 | -0.88 | -0.16 | -0.73 | -0.37 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -0.08 | 0.8 | Upgrade
|
| Net Income | -0.91 | -0.88 | -0.16 | -0.81 | 0.43 | Upgrade
|
| Net Income to Common | -0.91 | -0.88 | -0.16 | -0.81 | 0.43 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 0.13% | 0.14% | 1.44% | 0.03% | 0.03% | Upgrade
|
| EPS (Basic) | -0.06 | -0.06 | -0.01 | -0.05 | 0.03 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.06 | -0.01 | -0.06 | 0.03 | Upgrade
|
| Free Cash Flow | -0.45 | -0.39 | -0.26 | -0.1 | -0.1 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.02 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 39.92% | 38.14% | 45.14% | 41.23% | 43.49% | Upgrade
|
| Operating Margin | -10.83% | -9.20% | 4.52% | -3.45% | 1.85% | Upgrade
|
| Profit Margin | -22.45% | -17.13% | -2.99% | -14.91% | 6.70% | Upgrade
|
| Free Cash Flow Margin | -11.13% | -7.66% | -4.93% | -1.81% | -1.62% | Upgrade
|
| EBITDA | -0.27 | -0.29 | 0.4 | -0.03 | 0.23 | Upgrade
|
| EBITDA Margin | -6.77% | -5.58% | 7.66% | -0.55% | 3.54% | Upgrade
|
| D&A For EBITDA | 0.16 | 0.19 | 0.16 | 0.16 | 0.11 | Upgrade
|
| EBIT | -0.44 | -0.47 | 0.24 | -0.19 | 0.12 | Upgrade
|
| EBIT Margin | -10.83% | -9.20% | 4.52% | -3.45% | 1.85% | Upgrade
|
| Advertising Expenses | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.